Trademark: 98322723
Word
ENDOCRINE ACTIVITY INDEX
Status
Pending
Status Code
641
Status Date
Thursday, April 11, 2024
Serial Number
98322723
Mark Type
4000
Filing Date
Tuesday, December 19, 2023

Trademark Owner History

Classifications
44 Clinical diagnostic testing kits comprised of medical diagnostic reagents and assays for testing biopsy and other tissue samples for use in disease detection, namely, breast cancer; clinical diagnostic testing kits comprised of medical diagnostic reagents and assays for breast cancer surveillance, namely, clinical detection reagents and clinical kits for measuring amounts of genomic and other biomarkers contacted with the reagent, such as estrogen receptor (ER), progesterone receptor (PR) associated biomarkers, and other suitable biomarkers for monitoring breast cancer occurrence, recurrence, response to various chemotherapies, hormone therapies, radiation therapies, or other suitable treatments.
42 Clinical diagnostic testing kits comprised of medical diagnostic reagents and assays for testing biopsy and other tissue samples for use in disease detection, namely, breast cancer; clinical diagnostic testing kits comprised of medical diagnostic reagents and assays for breast cancer surveillance, namely, clinical detection reagents and clinical kits for measuring amounts of genomic and other biomarkers contacted with the reagent, such as estrogen receptor (ER), progesterone receptor (PR) associated biomarkers, and other suitable biomarkers for monitoring breast cancer occurrence, recurrence, response to various chemotherapies, hormone therapies, radiation therapies, or other suitable treatments.

Trademark Events
Apr 11, 2024
Notification Of Non-Final Action E-Mailed
Apr 11, 2024
Non-Final Action E-Mailed
Apr 11, 2024
Non-Final Action Written
Apr 8, 2024
Assigned To Examiner
Mar 29, 2024
New Application Office Supplied Data Entered
Dec 19, 2023
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24